Ultimate Medicine

Ultimate Medicine (UM) is a Swiss preclinical biotech focused on maximizing the healthspan of patients with Alzheimer's disease and other dementias. The company is pioneering a class of small molecules targeting elevated levels of a novel toxic metabolite that disrupts critical neuronal functions and accelerates disease progression. The company’s lead program is an oral small-molecule inhibitor designed to block metabolite synthesis.

Date, time and room information

Monday, May 4, 16:00 - 16:15, room Singapore

Category
Emerging biotech company
Title of the presentation
MAXIMIZING HEALTHSPAN: DEMENTIA, METABOLISM, AGING
Speaker information
Name Position Institution
Antal Szalay, MD, MBA CEO & Founder Ultimate Medicine